Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Completed

Conditions studied: Arthritis, Rheumatoid

In brief

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Key facts

Study ID

NCT00414661

Run by

Pfizer

People needed

162

Starts

2007-04-01

Expected to finish

2012-02-01

Last updated by the study team

2013-01-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have completed all participation in any other Phase 2B or Phase 3 studies of CP-690,550 for rheumatoid arthritis.

You may not qualify if…

• Any subject who refuses consent.

Where it is running

• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Palo Alto, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Stanford, California, United States
• Pfizer Investigational Site — Upland, California, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Sarasota, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Venice, Florida, United States
• Pfizer Investigational Site — Rockford, Illinois, United States
• Pfizer Investigational Site — Lincoln, Nebraska, United States
• Pfizer Investigational Site — Albany, New York, United States
• Pfizer Investigational Site — Hickory, North Carolina, United States
• Pfizer Investigational Site — Hickory, North Carolina, United States
• Pfizer Investigational Site — Wyomissing, Pennsylvania, United States
• Pfizer Investigational Site — Mesquite, Texas, United States
• Pfizer Investigational Site — Tacoma, Washington, United States
• Pfizer Investigational Site — Tacoma, Washington, United States
• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Buenos Aires, Argentina
• Pfizer Investigational Site — Goiânia, Goiás, Brazil
• Pfizer Investigational Site — Rio de Janeiro, Rio de Janeiro, Brazil
• Pfizer Investigational Site — Gilbert, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.